Mattia Veronese Selected Research

Subcutaneous Injections

1/2021

Increased serum peripheral C-reactive protein is associated with reduced brain barriers permeability of TSPO radioligands in healthy volunteers and depressed patients: implications for inflammation and depression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mattia Veronese Research Topics

Disease

26	Psychotic Disorders (Schizoaffective Disorder) 06/2022 - 01/2016
23	Schizophrenia (Dementia Praecox) 07/2022 - 01/2016
10	Neuroinflammatory Diseases 01/2022 - 06/2014
7	Multiple Sclerosis 01/2021 - 01/2016
5	Inflammation (Inflammations) 01/2021 - 01/2019
3	Bipolar Disorder (Manic Depressive Psychosis) 01/2021 - 12/2017
2	Paranoid Schizophrenia (Delusional Disorder) 07/2022 - 10/2020
2	Chronic Pain 01/2022 - 01/2022
2	Low Back Pain (Lumbago) 01/2022 - 01/2018
2	Autism Spectrum Disorder 01/2021 - 10/2018
2	Obesity 08/2020 - 01/2019
2	Demyelinating Diseases (Demyelinating Disease) 01/2020 - 12/2017
2	Cognitive Dysfunction 10/2019 - 01/2018
2	Alzheimer Disease (Alzheimer's Disease) 10/2019 - 03/2016
2	Fragile X Syndrome (Martin Bell Syndrome) 01/2019 - 01/2018
2	Hypoxia (Hypoxemia) 01/2019 - 11/2013
2	Mental Disorders (Mental Disorder) 11/2017 - 01/2017
1	Pain (Aches) 12/2022
1	Knee Osteoarthritis 01/2022
1	Brain Diseases (Brain Disorder) 01/2022
1	Fibromyalgia (Fibrositis) 01/2022
1	Necrosis 12/2021
1	Primary Progressive Aphasia 01/2021
1	Major Depressive Disorder (Major Depressive Disorders) 01/2021
1	Fatigue 01/2021
1	Atrophy 01/2021
1	Hallucinations (Hallucination) 10/2020
1	Dyslipidemias (Dyslipidemia) 08/2020
1	Substance-Related Disorders (Drug Abuse) 01/2019
1	Cardiotoxicity 01/2019
1	Craniocerebral Trauma (Head Injury) 10/2018
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2018

Drug/Important Bio-Agent (IBA)

18	Dopamine (Intropin)FDA LinkGeneric 07/2022 - 03/2017
15	Antipsychotic Agents (Antipsychotics)IBA 05/2021 - 03/2017
14	Proteins (Proteins, Gene)FDA Link 10/2021 - 06/2014
8	Biomarkers (Surrogate Marker)IBA 12/2022 - 01/2017
8	Dihydroxyphenylalanine (Dopa)IBA 06/2021 - 03/2017
5	Pharmaceutical PreparationsIBA 01/2022 - 12/2017
5	Amyloid (Amyloid Fibrils)IBA 01/2021 - 03/2016
4	LigandsIBA 12/2021 - 01/2018
4	CannabinoidsIBA 06/2021 - 10/2019
4	Glutamic Acid (Glutamate)FDA Link 06/2021 - 10/2018
3	Glucose (Dextrose)FDA LinkGeneric 06/2022 - 02/2016
3	N- benzyl- N- ethyl- 2- (7,8- dihydro- 7- methyl- 8- oxo- 2- phenyl- 9H- purin- 9- yl)acetamideIBA 10/2021 - 01/2018
3	(methyl- (11)C)N- acetyl- N- (2- methoxybenzyl)- 2- phenoxy- 5- pyridinamineIBA 01/2021 - 01/2018
3	Clozapine (Clozaril)FDA LinkGeneric 01/2021 - 03/2017
3	Polytetrafluoroethylene (Teflon)FDA Link 01/2021 - 10/2019
2	CytokinesIBA 01/2022 - 12/2021
2	Ketamine FDA LinkGeneric 12/2021 - 01/2021
2	Alanine (L-Alanine)FDA Link 01/2019 - 12/2017
2	Aminobutyrates (Aminobutyric Acid)IBA 10/2018 - 01/2017
1	Opioid Analgesics (Opioids)IBA 12/2022
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 12/2022
1	Neurotransmitter Receptors (Neurotransmitter Receptor)IBA 12/2022
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 06/2022
1	Pain-FreeIBA 01/2022
1	(R)- (11C)1- (2- chlorophenyl)- N- methyl- N- (1- methylpropyl)- 3- isoquinolinecarboxamideIBA 01/2022
1	Duloxetine Hydrochloride (Cymbalta)FDA Link 01/2022
1	Analgesics (Analgesic Drugs)IBA 01/2022
1	Biological ProductsIBA 01/2022
1	Oxytocin (Pitocin)FDA LinkGeneric 01/2022
1	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2022
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2021
1	InterferonsIBA 01/2021
1	LipopolysaccharidesIBA 01/2021
1	Monoamine Oxidase (MAO)IBA 01/2021
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2021
1	N,N- diethyl- 2- (2- (4- (2- fluoroethoxy)phenyl)- 5,7- dimethylpyrazolo(1,5- a)pyrimidin- 3- yl)acetamideIBA 01/2021
1	GABA Receptors (GABA Receptor)IBA 01/2021
1	Protein AggregatesIBA 01/2021
1	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	RacloprideIBA 01/2021
1	7- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA 01/2021
1	EndotoxinsIBA 01/2021
1	C-Reactive ProteinIBA 01/2021
1	gamma-Aminobutyric Acid (GABA)IBA 01/2021
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2021
1	GABA-A Receptors (GABA(A) Receptor)IBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Amphetamine (Amfetamine)FDA LinkGeneric 01/2021
1	Serotonin 5-HT1 Receptor AgonistsIBA 01/2021
1	Selegiline (E250)FDA LinkGeneric 01/2021
1	Neurotransmitter Agents (Neurotransmitter)IBA 11/2020
1	EndocannabinoidsIBA 08/2020
1	florbetapirIBA 01/2020
1	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 10/2019
1	IonophoresIBA 01/2019
1	Leucine (L-Leucine)FDA Link 01/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019
1	Carbonyl Cyanide m-Chlorophenyl Hydrazone (CCCP)IBA 01/2019
1	Technetium Tc 99m Sestamibi (Cardiolite)FDA LinkGeneric 01/2019
1	AnthracyclinesIBA 01/2019
1	Protons (Proton)IBA 10/2018
1	Propofol (Diprivan)FDA LinkGeneric 01/2018

Therapy/Procedure

1	Analgesia 01/2022
1	Catheters 12/2021
1	Subcutaneous Injections 01/2021
1	Contraindications 10/2018
1	Oral Administration 01/2018